Gonadorelin
GnRH, Luteinizing Hormone-Releasing Hormone, LHRH, Factrel
A synthetic decapeptide analog of GnRH that stimulates the pituitary gland to release FSH and LH, aiding in reproductive hormone regulation and fertility treatments.
Not Yet Recruiting
NA
NCT07212712
The Role of Estrogen and Testosterone in Determining Heart, Lung, and Brain Regulation in Humans
University of British Columbia
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE3
NCT00223145
Study on the Role of Hormonal Treatment for Two Dosage Levels of Prostate Radiation Therapy Versus Prostate Radiation Therapy Alone
Abdenour Nabid
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE2
NCT03879577
Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer
University of Chicago
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00044876
Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT03056755
Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior Treatments
Novartis Pharmaceuticals
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE2
NCT01776008
Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE4
NCT05038878
An Oral GnRH Antagonist to Treat Mild Autonomous Cortisol Excess (MACE) Due to Adrenal Adenomas in Postmenopausal Women
Icahn School of Medicine at Mount Sinai
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
PHASE2
NCT03940235
Radioablation With or Without Androgen DeprIvation Therapy in Metachronous Prostate Cancer OligometaStAsis
European Institute of Oncology
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2, PHASE3
NCT01300676
The Effects of Tualang Honey on Postmenopausal Women
Universiti Sains Malaysia
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT03298087
Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer
VA Office of Research and Development
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00586898
Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle
Memorial Sloan Kettering Cancer Center
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE1
NCT06631521
Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer
AdventHealth
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
PHASE1, PHASE2
NCT03881904
OCP Pretreatment in PCOS Patients Undergoing ICSI Using Antagonist Protocol
Ain Shams University
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT05473039
Effect of a Multivitamin Supplement With Probiotic (Seidivid Ferty4®) on Oocyte Retrieval and Quality
SEID S.A.
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
PHASE2
NCT04407065
Double Trigger in Patients With Low Number of Oocytes Retrieved Per Number of Preovulatory Follicles
Riyadh Fertility and Reproductive Health center
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE3
NCT04565054
Adjuvant Therapy With Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic High Risk, HR+/HER2- EBC
West German Study Group
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
PHASE4
NCT03477929
Cetrorelix and Ganirelix Flexible Protocol for (IVF)
Università degli Studi 'G. d'Annunzio' Chieti e Pescara
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2, PHASE3
NCT00296465
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH
Ferring Pharmaceuticals
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE3
NCT05207709
Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic Subtype
SOLTI Breast Cancer Research Group
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE4
NCT02959853
Aromatase Inhibitors and Weight Loss in Severely Obese Hypogonadal Male Veterans (Pilot)
Baylor College of Medicine
INTERVENTIONAL
Updated Dec 15, 2025